Moreover, reclassification of T cells in SCLC patients can better mirror the expression pattern of T cells dysfunction and exhaustion markers (such as HAVCR2, CTLA4, LAYN, PDCD1, LAG3, TIGIT), which may be used as immunotherapeutic targets. This evidence concerns the gene CTLA4 and small cell lung carcinoma.